Androgens
Showing 26 - 50 of 734
PCOS, Vitamin D Trial in Dhaka (Vitamin D3, Placebo Oral Tablet)
Recruiting
- PCOS
- Vitamin D
- Vitamin D3
- Placebo Oral Tablet
-
Dhaka, BangladeshBSMMU
Oct 29, 2023
Prostate Cancer, Prostate Adenocarcinoma Trial (drug, other, procedure)
Not yet recruiting
- Prostate Cancer
- Prostate Adenocarcinoma
- Relacorilant
- +4 more
- (no location specified)
Feb 2, 2023
Paraphilia Trial in Paris (behavioral, other, biological, genetic)
Not yet recruiting
- Paraphilia
- Evaluation Scales
- +4 more
-
Paris, FranceHôpital Cochin
Oct 31, 2022
Congenital Adrenal Hyperplasia Trial in United States (Abiraterone acetate)
Active, not recruiting
- Congenital Adrenal Hyperplasia
- Abiraterone acetate
-
Los Angeles, California
- +3 more
Feb 22, 2022
Urinary Incontinence, Menopause Trial (Testosterone Enanthate, Placebo)
Withdrawn
- Urinary Incontinence
- Menopause
- Testosterone Enanthate
- Placebo
- (no location specified)
Jul 18, 2022
Telomere Disease Trial run by the NHLBI (Danazol)
Recruiting
- Telomere Disease
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Prostate Carcinoma, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in Houston (drug, procedure,
Recruiting
- Prostate Carcinoma
- +6 more
- Abiraterone Acetate
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Aug 10, 2022
Metastatic Malignant Tumor in Lymph Node, Prostate Ductal Adenocarcinoma, Stage III Prostate Adenocarcinoma AJCC v7 Trial in
Active, not recruiting
- Metastatic Malignant Neoplasm in Lymph Node
- +3 more
- Antiandrogen Therapy
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Mar 3, 2022
Diabetes, Type 2, Dyslipidemia Associated With Type II Diabetes, Statin Adverse Reaction Trial in Tunis (Atorvastatin 40 Mg Oral
Completed
- Diabetes Mellitus, Type 2
- +5 more
- Atorvastatin 40 Mg Oral Tablet
-
Tunis, TunisiaUniversity Hospital La Rabta
Apr 7, 2023
Treatment of Hypertrichosis With Intense Pulsed Light
Not yet recruiting
- Hypertrichosis
- Hirsutism - Hypertrichosis
- Intense pulsed light
-
Umeå, Västerbotten, SwedenNorrlands University Hospital
Mar 20, 2023
Adenocarcinoma of the Prostate Trial in Montreal (Androgen suppression plus radiation therapy)
Active, not recruiting
- Adenocarcinoma of the Prostate
- Androgen suppression plus radiation therapy
-
Montreal, Quebec, Canada
- +1 more
Jan 30, 2023
Hypertension, Hyperlipidemias Trial in New Haven (Atorvastatin, )
Withdrawn
- Hypertension
- Hyperlipidemias
- Atorvastatin
- placebo
-
New Haven, ConnecticutYale School of Medicine
Oct 31, 2022
Dissecting Androgen Excess and Metabolic Dysfunction in
Recruiting
- Polycystic Ovary Syndrome
- Women with polycystic ovary syndrome
-
Birmingham, West Midlands, United KingdomWellcome Trust Clinical Research Facility
Feb 22, 2022
SMART Protocol vs Antagonist Protocol in IVF
Active, not recruiting
- Diminished Ovarian Reserve
-
Montreal, Quebec, CanadaClinique Ovo
Dec 22, 2022
Pharmacokinetics, Hormone Deficiency Trial in Santiago (Dehydroepiandrosterone 2.2 g, Dehydroepiandrosterone 1.5 g/Testosterone
Completed
- Pharmacokinetics
- Hormone Deficiency
- Dehydroepiandrosterone 2.2 g
- +4 more
-
Santiago, ChileInstituto de Investigación Materno Infantil (IDIMI) - Maternidad
May 27, 2019
Aqueous Tear Deficiency, Meibomian Gland Dysfunction of Bilateral Eyes (Disorder) Trial in Fullerton (Testosterone gel 4.5%,
Recruiting
- Aqueous Tear Deficiency
- Meibomian Gland Dysfunction of Bilateral Eyes (Disorder)
- Testosterone gel 4.5%
- Vehicle gel
-
Fullerton, CaliforniaSouthern California College of Optometry at Marshall B. Ketchum
Nov 29, 2023
Metastatic Hormone-sensitive Prostate Cancer Trial in United States (androgen-deprivation therapy, docetaxel)
Active, not recruiting
- Metastatic Hormone-sensitive Prostate Cancer
- androgen-deprivation therapy
- docetaxel
-
Anchorage, Alaska
- +342 more
Jan 29, 2023
High-risk Prostate Cancer, Neoadjuvant Therapy Trial in Shanghai (Abiraterone acetate, Fluzoparib, Prednisone)
Recruiting
- High-risk Prostate Cancer
- Neoadjuvant Therapy
- Abiraterone acetate
- +4 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Oct 6, 2022
Innate Immune Cells Trial in Hershey (Cogni.Q, Placebo)
Recruiting
- Innate Immune Cells
- Cogni.Q
- Placebo
-
Hershey, PennsylvaniaPenn State College of Medicine
Feb 11, 2022
Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in Columbus (Arm I Soy Bread, Arm II Soy-Almond Bread)
Active, not recruiting
- Recurrent Prostate Cancer
- Stage IV Prostate Cancer
- Arm I Soy Bread
- Arm II Soy-Almond Bread
-
Columbus, OhioThe Ohio State University Medical Center
Apr 29, 2022
Invasive Ductal Breast Carcinoma Trial in Clamart (Degarelix injection(s))
Completed
- Invasive Ductal Breast Carcinoma
- Degarelix injection(s)
-
Clamart, FranceHôpital Antoine Béclère
Sep 26, 2022
Prostate Cancer, Biochemical Recurrence Trial in Nanjing (Rezvilutamide, Androgen deprivation therapy (ADT), SRT)
Recruiting
- Prostate Cancer
- Biochemical Recurrence
- Rezvilutamide
- +2 more
-
Nanjing, Jiangsu, China
- +1 more
Mar 2, 2023
Preserving Fertility After Colorectal Cancer Study
Recruiting
- Colorectal Cancer
-
Nashville, TennesseeVanderbilt-Ingram Cancer Center
Feb 1, 2022
Newly-diagnosed Polymyalgia Rheumatica and Giant Cell Arteritis
Recruiting
- Polymyalgia Rheumatica (PMR)
- Giant Cell Arteritis (GCA)
- Data collection for cellular analyses (Immune subset composition, GCR expression, in vitro steroid responsiveness)
- +3 more
-
Basel, SwitzerlandDepartment of Rheumatology University Hospital Basel
Aug 2, 2022